INTRODUCTION
The classical complement pathway is activated when its first component Cl interacts via its Cl q subcomponent with the Fc regions of aggregated IgG. This interaction provides the link between the recognition of antigen by immunoglobulin and its destruction, mediated by the classical complement pathway (reviewed in [1] ). The precise location of the Cl q-binding site on IgG is not yet known, despite being the object of many investigations; these studies have used techniques such as enzymic digestion [2, 3] , amino acid sequence comparison, solvent exposure and charge characteristics of potential binding sites [4, 5] , properties of specific inhibitors of the interaction [4] [5] [6] [7] [8] [9] [10] [11] and chemical modification of amino acid residues on IgG [4, 6, 7, [12] [13] [14] [15] [16] [17] . Consideration of the data arising from these studies has led to two regions of the CH2 domain being proposed as possible Clq-binding sites: residues 275-295 (site A [8, 18] ) and residues 316-338 (site B [4, 16] [22] . Protein concentrations were determined assuming A280 = 1.4 for a 1 mg/ml solution of IgG [23] or from radioactivity measurements when trace amounts of "251-labelled IgG were added after nitration but before dialysis. Dithionite treatment Nitrated protein was incubated at room temperature for 5 min with 1 mM-Na2S204 in phosphate-buffered saline. The extent of reduction (from nitrotyrosine to aminotyrosine residues) was determined from the loss of absorbance at 428 nm and the concomitant gain at 288 nm assuming £288 = 2200 M-1 *cm-' [24] ; samples were dialysed against phosphate-buffered saline before being assayed for Clq-binding activity.
SDS/PAGE
Electrophoresis was done by the method of Laemmli
[251 and gels were silver-stained by the method of Wray et al. [26] . Amino acid analysis This was performed with a Waters Pico-Tag analysis system, according to the manufacturer's instructions, on samples that had been hydrolysed in 6 M-HCI for 24 h at 110°C in vacuo.
H.p.l.c.
H.p.l.c. was performed in an LKB 2150/1/2 system obtained from LKB, Bromma, Sweden. Plots and calculations were recorded with a LDC/Milton Roy CI-10 integrator and Sekonics thermal printer. Separations were achieved on an LKB Lichrosorb C18 (10 ,um particle size) reverse-phase column (25 cm x 0.4 cm). Tryptic digestion Nitrated protein (10 mg/ml in phosphate-buffered saline) was incubated at 37°C with 0.01 M-dithiothreitol for 1 h; the reaction mixture was then made 0.02 M with respect to iodoacetamide and incubated at room temperature in the dark for 30 min. The reduced and alkylated IgG was then separated from the reaction products by extensive dialysis against 0.1 M-ammonium bicarbonate buffer, pH 8.4 . The nitrated protein (approx. 5 mg/ml in 0.1 M-ammonium bicarbonate buffer, pH 8.4) was incubated at 37°C for 1 h with trypsin (1 % by wt. of protein) and then for a further 30 Role of tyrosine residues in IgG in binding of Clq work of Niederwieser [27] . Tryptic digests of nitrated IgG were adjusted to pH 2 with HCI and then applied to a 2 ml column of Porapak Q equilibrated with 0.1 M-HCl at room temperature. The column was washed with approx. 10 ml of 0.1 M-HCI to remove unbound peptides. Nitrotyrosine-containing peptides were then eluted with acetonitrile/0.1 M-sodium acetate, pH 5 (1:1, v/v), and subjected to h.p.l.c. analysis.
RESULTS

Effect of tetranitromethane treatment on the
Clq-binding activity of IgG Treatment of chemically cross-linked aggregates of human IgG with the tyrosine-selective reagent tetranitromethane decreased their Clq-binding activity; no such activity loss was exhibited by chemically crosslinked rabbit IgG oligomers that had been treated identically (Fig. 2a) . A similar trend was observed when the Clq-binding activity of heat-aggregated IgG oligomers was examined after tetranitromethane treatment, with human IgG but not rabbit IgG oligomers showing diminished activity upon nitration (Fig. 2b) . The Clqbinding activity of rabbit IgG in the form of insoluble immune complexes was also unaffected by tetranitromethane modification (Fig. 3) . Together, these results suggest the presence of critical tyrosine residues at or near the Clq-binding site of human IgG (but not rabbit IgG).
Specificity of IgG modification
The spectral changes observed upon nitration of both human IgG and rabbit IgG aggregates were consistent with the modification of tyrosine residues; the nitrated protein in alkaline conditions exhibited a maximum at 410 nm, which is characteristic of nitrotyrosine residues. Moreover, when these samples were subjected to amino acid analysis no novel amino acid residues except nitrotyrosine were detected. It would thus appear that tetraVol. 257 nitromethane is specific for tyrosine residues in both human IgG and rabbit IgG. Stoichiometry of IgG modification Table 1 shows the correlation of the extent of nitration of IgG aggregates with their Clq-binding activities. Nitration of an average of 10.2 tyrosine residues/molecule in both chemically cross-linked and heat-aggregated human IgG led to loss of up to 820 of its Clq-binding activity. On the other hand, modification of similar numbers of tyrosine residues in rabbit IgG aggregates had little effect on its Clq-binding activity. Mechanism of the inactivation The mechanism by which nitration of tyrosine residues in human IgG inactivates its Clq-binding sites was studied by examining the effects of treating the modified protein with Na2S204. This reagent is able to reduce nitrotyrosine residues to aminotyrosine residues; this has a limited effect on the size of the incorporated group but restores the pK of the phenolic hydroxy group from approx. 7 in a nitrotyrosine residue to approx. 10 in an aminotyrosine residue [24] .
Reduction of nitrotyrosine residues to aminotyrosine residues did not restore Clq-binding activity in human IgG aggregates, nor did it lead to loss of Clq-binding activity in rabbit IgG aggregates (Table 2) . Controls were performed showing that Na2S204 treatment of human IgG and rabbit IgG aggregates did not abrogate their Clq-binding activities. These observations imply that nitration of tyrosine residues in human IgG aggregates abrogates Clq-binding activity through the introduction of a bulky nitro side group causing steric hindrance of the Clq-IgG interaction rather than through alteration of the pK of the phenolic hydroxy groups of the tyrosine residues. Monitoring of the loss of A428 (due to nitrotyrosine residues) and the increase in A288 (due to aminotyrosine residues) showed that the Na2S204 reduction ofnitrotyrosine residues was complete within 5 min at room temperature.
It has been reported that tetranitromethane can lead to cross-linking of proteins, including rabbit IgG [28] . These observations were confirmed when SDS/polyacrylamide-gel electrophoresis was performed under reducing conditions to determine the extent of crosslinking; both human IgG and rabbit IgG oligomers were covalently coupled by tetranitromethane. The degree of cross-linking increased with increasing concentrations of both modifier and protein and at low pH. At pH 7.2, the pH at which tetranitromethane modification studies were performed, the extent to which IgG oligomers were cross-linked was estimated to be approx. 10 %. t Tabulated as tyrosine residues for theoretical compositions.
tetranitromethane arose from modification of Tyr-319 (in site B) or nitration of Tyr-278 (in site A), it was necessary to isolate and characterize nitrotyrosinecontaining peptides from both human IgG and rabbit IgG.
In preliminary experiments, samples of nitrated human IgG were reduced and alkylated, and then treated with trypsin as indicated in the Materials and methods section. However, although five 360 nm-absorbing peptides could be detected when these digests were subjected to h.p.l.c. analysis, it was not possible to purify them from co-eluted unlabelled peptides.
Because of this problem, a new strategy was developed for affinity purification of the nitrotyrosine-containing peptides from the unlabelled peptide milieu that results from trypsin digestion. This method makes use of a Porapak Q liquid-chromatography column to retain only nitrated peptides. These labelled peptides are then recovered (> 95 % yield) by elution with organic solvent before h.p.l.c. When the nitrated tryptic peptides from human IgG and rabbit IgG were purified on Porapak Q before h.p.l.c., the h.p.l.c. profiles shown in Fig. 4 were obtained. The amino acid compositions of these peptides are presented in Table 3 . The expected tryptic peptide containing Tyr-319 (E-YNO,-K) from human IgG was not found; however, a peptide containing one cysteine, two lysine, one glutamate and one nitrotyrosine residues was isolated. This composition fits uniquely the sequence for residues 318-322 of human IgG: E-YNO -K-C-K. Table 3 also shows that a peptide with amino acid composition fitting a tryptic fragment surrounding Tyr-278 was isolated from both rabbit IgG and human IgG. These data suggest that this residue is not important for the binding of Cl q by either species of IgG. DISCUSSION The present study was designed to distinguish between two candidate Clq-receptor sites on IgG from the IgG species' susceptibility to inactivation by modification of tyrosine residues. Although both rabbit IgG and human IgG contain Tyr-278 in site A, only human IgG has a tyrosine residue (Tyr-319) within site B. Thus strong evidence for site B containing the Clq-receptor site would be obtained by demonstrating that human IgG is inactivated when Tyr-319 is modified, and that rabbit IgG is insensitive to modification of tyrosine residues. The chemical modifier used, tetranitromethane, is reasonably specific for tyrosine residues, although the reaction with thiol groups and histidine, methionine and tryptophan residues has been reported [29] [30] [31] ment was in marked contrast with the lack of effect in nitrated aggregates of rabbit IgG (Fig. 2) . These observations suggest the presence of critical tyrosine residues at or near the Clq-binding site of human IgG (but not rabbit IgG); thus the data support site B with the unique Tyr-3 19. The possibility of nitration-induced conformational change in human IgG (other than at the Clq-binding site) being the cause of inactivation is remote because, as shown in Table 1 , rabbit IgG aggregates, which were nitrated to a similar extent (approx.
25 % of all tyrosine residues), remained active.
The modification with tetranitromethane of tyrosine residues in human IgG has been reported previously by Johnson & Thames [17] . In that paper it was noted that modification of an average of 7.3 tyrosine residues per human IgG molecule led to a 720% decrease in anticomplementary activity; our data are in agreement with these observations. Ths study by Johnson & Thames [17] differed from the present work in that it relied on adsorbing the modified IgG on latex beads before the haemolytic assay, did not measure directly Clq-binding activity, examined only human IgG and did not identify the residues modified.
The reaction of tetranitromethane with tyrosine produces 3-nitrotyrosine, nitroformate and two protons; the PKa of the phenolic hydroxy group subsequently changes from approx. 10 to approx. 7 owing to the effect on the ring electrons caused by substitution of the nitro group for the hydrogen atom [24] . Thus the loss of Cl q-binding activity in nitrated aggregates of human IgG may be the result of two factors. First, steric hindrance by the nitro group (introduced in place of a hydrogen atom) could disrupt the appropriate interactions required for ClqIgG binding. Alternatively, or concomitantly, the change in pKa of the phenolic group from 10 to 7 may lead to loss of Clq binding through generation of unfavourable charge interactions between Clq and human IgG aggregates. Dithionite reduction of the nitrated protein, which restores the pK of a modified residue to approx. 10, failed to restore lost Clq-binding activity to nitrated human IgG oligomers and did not affect the C I q-binding activity of nitrated rabbit IgG oligomers. This implies that steric hindrance by the bulky nitro group is the cause of human IgG inactivation, rather than alteration of the charges of modified tyrosine residues.
The small degree of tetranitromethane-mediated cross-linking of IgG oligomers that occurred under the conditions used was judged to be irrelevant to this study because the same (minor) extent of cross-linking occurred in both human IgG and rabbit IgG oligomers. Also, it would be expected that further aggregation of oligomers would lead, if anything, to a small increase rather than the observed large decrease in Clq-binding activity of nitrated human IgG oligomers.
Two criteria needed to be met for the isolation and identification of nitrotyrosine-containing peptides. First, under the acidic conditions of peptide separation by reverse-phase h.p.l.c., these peptides should be distinguishable from those without modified tyrosine residues. Secondly, the peptides should have non-ambiguous amino acid composition so that confident identification can be made from the amino acid analysis. The isolation of the nitrotyrosine-containing tryptic peptides from the digests of nitrated IgG was greatly facilitated by the use of Porapak Q chromatography. Removal of the unlabelled peptides (which had confused the initial amino acid analysis) by this 'affinity' step meant that the results of further characterization (h.p.l.c. and amino acid analyses) were easier to interpret. The tryptic digest of nitrated human IgG yielded a peptide whose amino acid composition fitted uniquely the sequence for residues 318-322. The assignment of this peptide was made easier by the presence of the carboxymethylcysteine, since there are only 11 such residues per half IgG molecule. A possible explanation for the fact that trypsin did not cleave after Lys-320 is that this residue is flanked by bulky groups: the carboxymethylcysteine residue at position 321 and the nitrotyrosine residue at position 319. In addition, peptides corresponding to those expected for the tryptic fragments containing Tyr(NO2)-278 were isolated from digests of both human IgG and rabbit IgG, implying that the region adjacent to this residue is not important for Clq binding. As identification of the other nitrotyrosine-containing peptides was not made, we cannot rule out the possibility that modification of residues outside of the CH2 domain was responsible for the differential effects exerted by nitration of human IgG and rabbit IgG. However, we are not aware of any reports of modification of residues outside the CH2 domain directly affecting the Cl q-binding activity of IgG.
We have shown previously that modification of histidine residues (presumably His-324) on rabbit IgG abrogated its Clq-binding activity [21] . These findings reinforce the conclusion drawn from the current work: Tyr-3 19 is involved in the binding of Clq by human IgG and thus the Clq-receptor site on IgG is encompassed within the site proposed by Burton et al. [4] , namely residues 316-338.
Since submission of this paper, Duncan & Winter [32] have reported similar conclusions about the location of the Clq-binding site, based on the effects of site-directed mutagenesis of human IgG1.
